MedPath

Rice Anthocyanin Bioavailability in Humans

Not Applicable
Completed
Conditions
Healthy
Interventions
Other: Rice
Registration Number
NCT03935022
Lead Sponsor
University of Milan
Brief Summary

Aims of the project

1. To determine the rice anthocyanin content via high-performance liquid chromatographycoupled to mass spectrometry, HPLC-MS

2. To study the oral bioavailability of anthocyanins in healthy volunteers after the intake of a serving (80 g) of black rice (Venere and Artemide varieties).

3. To determine the plasma biokinetics parameters of rice anthocyanins via spectrophometric determination and high-performance liquid chromatographycoupled to mass spectrometry, HPLC-MS.

Detailed Description

To limit the interindividual variability, The protocol will be designed as a prospective, randomized, cross-over pharmacokinetic study on healthy volunteers. Participants will be randomly divided into three groups (black rice Venere, black rice Artemide and white rice/control) by an allocation software ( http://graphpad.com/quickcalcs/randomise1.cfm ) which will generate different random sequences of the treatment assignment.

Subjects will be deprived of anthocyanin-rich food sources 7 days before experimentation (wash-out period). Each volunteer will receive a complete list of anthocyanin-rich foods to be avoided, including berry fruits (i.e. blueberries, cranberries, raspberries, blackcurrants and elderberries), red/violet fruits/vegetables (i.e. grapes, cherries, pomegranates, red apples, plums, eggplants, tomatoes and peppers), red wine and other colored products (i.e. marmalade, jams and juices containing berries). Breakfast, lunch and dinner will be standardized 1 day before the experiment. Each group will randomly receive, during three different experimental days, one of the following treatments by different allocation sequences:

1. 80g of black rice Venere (Group A)

2. 80g of black rice Artemide (Group B)

3. 80g of white rice (Group C)

Therefore, each subject will be involved in three experimental days. The three treatments will be separated by a 7 day wash-out period.

After an overnight fast, volunteers will consume the rice serving within 10-15 min, immediately after the first basal blood collection at 8:00 a.m. (baseline). Other blood withdrawals will be collected after 30 minutes, 1 hour, 2 hours, 3 hours.

Chemical analyses. The extraction protocols of anthocyanins from body fluids will be developed, in order to reach the maximum yield of the analytes from the samples. Plasma anthocyanins will be measured by spectrophometric determination and high-performance liquid chromatographycoupled to mass spectrometry, HPLC-MS.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Healthy status
  • Age: 18-45
  • Normal weight (BMI 18.5-24.9) who voluntarily accept to join the study, after informed consent.
Exclusion Criteria
  • <18 Years;
  • Pregnancy and lactation;
  • Systemic disorders;
  • Dietary supplements intake (vitamins, antioxidants, botanicals, phytochemicals)
  • Abnormal hematological parameters;
  • Heavy smoking and alcohol drinking;
  • High-intensity physical activity.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Black rice ArtemideRiceHealthy volunteers will receive the black rice Artemide in a cross-over randomized clinical trial (after 7 days wash-out).
Complete white riceRiceHealthy volunteers will receive the complete white rice in a cross-over randomized clinical trial (after 7 days wash-out).
Black rice VenereRiceHealthy volunteers will receive the black rice Venere in a cross-over randomized clinical trial (after 7 days wash-out).
Primary Outcome Measures
NameTimeMethod
Changes in plasma total anthocyanin detection0.0 (baseline, before starting the intervention), then after 0.5 hour, 1 hour, 2 hours and 3 hours

Total anthocyanins will be detected via spectrophometric determination; expressed as μg of catechin per mL of plasma

Changes in plasma Cyanidin-3-O-glucoside detection0.0 (baseline, before starting the intervention), then after 0.5 hour, 1 hour, 2 hours and 3 hours

Cyanidin-3-O-glucoside will be detected via high-performance liquid chromatographycoupled to mass spectrometry, HPLC-MS) in plasma; expressed nM (nano molar) in plasma

Secondary Outcome Measures
NameTimeMethod
Changes in plasma antioxidant capacity ABTS0.0 (baseline, before starting the intervention), then after 0.5 hour, 1 hour, 2 hours and 3 hours

2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS+); the results are expressed as Trolox equivalent antioxidant capacity (TEAC, mmoleq Trolox/mL plasma)

Changes in plasma antioxidant capacity DPPH0.0 (baseline, before starting the intervention), then after 0.5 hour, 1 hour, 2 hours and 3 hours

2,2-diphenyl-1-picrylhydrazyl (DPPH); percentage of inhibition (I%) is calculated as \[(ABScontrol 517 nm - ABSsample 517 nm/ABScontrol 517 nm)×100\]

Trial Locations

Locations (1)

Marcello Iriti

🇮🇹

Milano, MI, Italy

© Copyright 2025. All Rights Reserved by MedPath